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Abstract
Background Infl uenza is an important public health problem, with potential severe consequences among people with 
chronic diseases. The aim of this study was to obtain reliable measures of seasonal infl uenza vaccine uptake in this 
population, otherwise not available in Italy.
Methods Progressi delle Aziende Sanitarie per la Salute in Italia (PASSI) is a nationwide surveillance system 
of health-related behaviours and acceptance of preventive interventions (including infl uenza immunisation) off ered 
by the Italian National Health Service. Data are collected with telephone interviews at local health unit level 
for supporting local activities. The survey sample is randomly selected from local health unit lists of adult residents. 
The trend of annual vaccine coverage since 2008 was estimated for people aged 18–64 years who reported having at 
least one chronic disease. To obtain a suffi  cient sample size in subgroups, we analysed the characteristics of vaccinated 
people in the 2010–13 cumulative dataset. Univariate, multivariate, and logistic regression analyses were undertaken.
Findings In 2008–13, 13 659 individuals with at least one chronic disease were interviewed. Vaccination coverage fell 
signifi cantly from 29·7% (95% CI 27·2–32·4) in 2007–08 to 19·9% (18·0–22·1) in 2012–13. During 2010–13, the overall 
proportion of vaccinated people with a chronic disease was 25·6% (24·5–26·7). Vaccine coverage of people with 
diabetes (34·3%, 31·7–36·9) or cardiovascular diseases (31·8%, 29·6–34·2) was greater than that of people aff ected 
by renal failure, respiratory diseases, tumours, or chronic liver diseases (26·5% [22·5–30·7], 24·9% [23·2–26·7], 22·2% 
[20·0–24·6], and 20·6% [17·5–24·6], respectively). Vaccination coverage increased with age (from 13·1% [11·0–15·5] 
in the 18–34 year age group to 33·4% [31·9–35·1] in people aged 50–64 years); it was higher among people with a low 
educational level than among those with a high educational level, higher in those having economic diffi  culties than 
in those with no economic diffi  culties, and higher among Italian citizens than among non-citizens.
Interpretation In the past few years, prevalence of infl uenza vaccination in Italian adults with at least one chronic 
disease was well below the Ministry of Health's goal (75% minimum) and showed a downward trend. A major reason 
of this evolution is probably the changing public perception of the benefi ts and risks of vaccines. PASSI is a source 
of useful data not otherwise available for public health intervention.
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